Good Day BIO Newsletter

If you need a dose of positivity to start your week, listen to the new episode of the I AM BIO Podcast, in which a top neurologist and neuroscientist provides reasons to hope we could see Alzheimer’s therapeutics soon. We also discuss what the election could mean for industrial biotech, including renewable fuels and synthetic biology. Here are 800 words, 4 minutes.

Closing the week with a call for support for scientists—as well as a look at why recycling isn’t the only solution to the plastic problem. (You should still recycle, though.) Here are around 820 words, 4 minutes. P.S. EveryLife Foundation for Rare Diseases wants to understand the rare disease community’s perception of a COVID-19 vaccine. People living with a rare disease and/or providing care for someone with a rare disease are invited to take this anonymous 10-15 minute survey on COVID-19…

Today we have an update on the COVID-19 vaccine development race and a look at a new Manufacturing Innovation Institute (MII) that will drive the bioeconomy forward. Read to the end for more on the flurry of activity in D.C. ahead of tonight’s final presidential debate. Here are 770 words, just under 4 minutes.

We all know COVID-19 is exacerbating racial disparities in the United States. But why? We take a deep dive, plus give you more industry and D.C. news you need to know, in around 740 words, 3 minutes, 40 seconds.

Election Day is officially two weeks away. If you still need to figure out a voting plan or read up on the candidates in your state races, visit Biotech Votes. Today, we catch up on the latest COVID-19 vaccine news and get insights on the future of CRISPR, in 685 words, or 3 minutes, 30 seconds.

We’re starting a new week with an inspiring podcast episode featuring a biotech company working to combat climate change and racial injustice—and also produce innovative therapies. We have details, plus a closer look at Twist Bioscience’s announcement about a new partnership to expedite CAR T cancer treatments, in around 880 words, 4 and a half minutes.

BREAKING NEWS: The Wall Street Journal reports that Pfizer could apply for emergency use of a COVID-19 vaccine by late November. Pfizer CEO Albert Bourla published an open letter to speak directly to the public about the company's plans.In other news, the FDA approved the first drug to treat Ebola virus, which is a major breakthrough as Ebola continues to spread. We have details, plus what former VP Joe Biden said about carbon capture and renewable energy, in around 770 words, just under 4…

Day 2 of BIO Investor Forum Digital brought insights into how the FDA is handling the pandemic, the outlook for biotech markets and drug pricing policy, and practical advice on how to improve diversity and inclusion. As usual, Washington news at the end. Here are around 1,000 words, 5 minutes.

We recap a fantastic first day of BIO Investor Forum Digital, with a look at VC investment trends, the latest news from the AMR Action Fund, and why diversity matters in clinical trials and in companies. It's all below, plus your usual news from Washington, in just under 1,000 words, just under 5 minutes.

BIO Investor Forum Digital begins today—and we give you a sneak peek at what you’ll hear from both investors and emerging companies, as well as tell you how to follow along. We also take a closer look at COVID-19 and the world’s plastic problem and what’s happening in Washington. Here are around 785 words, just under 4 minutes.